Atara Biotherapeutics Inc (ATRA) Insider Trading
- $3,819,989.71
- $54,474,671.30
- Nov. 18, 2024
- Isaac E Ciechanover
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 18, 2024 | CFO | 1,364 | $11.20 | Sell | $15,276.80 | |
Nov. 18, 2024 | EVP | 1,000 | $11.20 | Sell | $11,200.00 | |
Nov. 18, 2024 | CEO | 1,664 | $11.20 | Sell | $18,636.80 | |
Aug. 16, 2024 | CFO | 1,070 | $6.63 | Sell | $7,094.10 | |
Aug. 16, 2024 | EVP | 1,821 | $6.63 | Sell | $12,073.23 | |
Aug. 16, 2024 | CEO | 3,038 | $6.63 | Sell | $20,141.94 | |
May 16, 2024 | EVP | 42,899 | $0.62 | Sell | $26,597.38 | |
May 16, 2024 | CEO | 81,506 | $0.62 | Sell | $50,533.72 | |
May 16, 2024 | CFO | 28,648 | $0.62 | Sell | $17,761.76 | |
March 4, 2024 | EVP | 10,746 | $0.72 | Sell | $7,737.12 | |
March 4, 2024 | CEO | 24,844 | $0.72 | Sell | $17,887.68 | |
Nov. 16, 2023 | CEO | 20,409 | $0.39 | Sell | $7,959.51 | |
Nov. 16, 2023 | CFO | 11,958 | $0.39 | Sell | $4,663.62 | |
Nov. 16, 2023 | EVP | 8,856 | $0.39 | Sell | $3,453.84 | |
Nov. 13, 2023 | Director | 179,020 | $0.22 | Buy | $39,384.40 | |
Nov. 10, 2023 | Director | 100,000 | $0.25 | Buy | $25,000.00 | |
Aug. 16, 2023 | CEO | 30,766 | $1.65 | Sell | $50,763.90 | |
Aug. 16, 2023 | CFO | 8,186 | $1.65 | Sell | $13,506.90 | |
Aug. 16, 2023 | EVP | 8,672 | $1.65 | Sell | $14,308.80 | |
June 27, 2023 | CEO | 14,291 | $1.66 | Sell | $23,723.06 | |
May 16, 2023 | CEO | 29,766 | $2.04 | Sell | $60,722.64 | |
May 16, 2023 | EVP | 8,389 | $2.04 | Sell | $17,113.56 | |
May 16, 2023 | CFO | 7,918 | $2.04 | Sell | $16,152.72 | |
March 2, 2023 | CFO | 6,871 | $3.63 | Sell | $24,941.73 | |
March 2, 2023 | CEO | 15,679 | $3.63 | Sell | $56,914.77 | |
March 2, 2023 | EVP | 5,074 | $3.63 | Sell | $18,418.62 | |
March 2, 2023 | SVP | 4,221 | $3.63 | Sell | $15,322.23 | |
Feb. 7, 2023 | CFO | 2,485 | $5.46 | Sell | $13,568.10 | |
Nov. 16, 2022 | EVP | 4,342 | $4.49 | Sell | $19,495.58 | |
Nov. 16, 2022 | CEO | 15,591 | $4.49 | Sell | $70,003.59 | |
Nov. 16, 2022 | SVP | 3,612 | $4.49 | Sell | $16,217.88 | |
Nov. 16, 2022 | CFO | 6,255 | $4.49 | Sell | $28,084.95 | |
Aug. 16, 2022 | CFO | 5,940 | $5.04 | Sell | $29,937.60 | |
Aug. 16, 2022 | CEO | 14,806 | $5.04 | Sell | $74,622.24 | |
Aug. 16, 2022 | SVP | 3,430 | $5.03 | Sell | $17,252.90 | |
Aug. 16, 2022 | EVP | 4,124 | $5.03 | Sell | $20,743.72 | |
June 27, 2022 | CEO | 14,220 | $7.20 | Sell | $102,384.00 | |
May 17, 2022 | CEO | 13,913 | $5.32 | Sell | $74,017.16 | |
May 17, 2022 | EVP | 3,873 | $5.32 | Sell | $20,604.36 | |
May 17, 2022 | SVP | 3,223 | $5.32 | Sell | $17,146.36 | |
May 17, 2022 | CFO | 5,582 | $5.32 | Sell | $29,696.24 | |
Feb. 10, 2022 | EVP | 5,000 | $16.00 | Sell | $80,000.00 | |
Feb. 7, 2022 | CFO | 2,496 | $14.46 | Sell | $36,092.16 | |
Nov. 16, 2021 | CFO | 3,655 | $17.12 | Sell | $62,573.60 | |
Nov. 16, 2021 | EVP | 2,199 | $17.12 | Sell | $37,646.88 | |
Nov. 16, 2021 | CEO | 8,402 | $17.12 | Sell | $143,842.24 | |
Nov. 16, 2021 | SVP | 2,124 | $17.12 | Sell | $36,362.88 | |
Nov. 15, 2021 | Insider | 7,000 | $17.71 | Sell | $123,970.00 | |
Nov. 4, 2021 | Director | 13,354 | $19.50 | Sell | $260,403.00 | |
Nov. 2, 2021 | EVP | 5,000 | $16.41 | Sell | $82,050.00 |
Insiders are both buying and selling Atara Biotherapeutics Inc stock.
The insider traders at Atara Biotherapeutics Inc are: Isaac E Ciechanover, Joe Newell, Christopher Haqq, Carol Giltner Gallagher, John Mcgrath, Pascal Touchon, Utpal Koppikar, Gad Soffer, Amar Murugan, Jakob Dupont, Eric J Hyllengren, Mitchall G Clark, Anhco Nguyen, Derrell Porter, Joel S Marcus, Eric Dobmeier, Kristin Yarema, Matthew K Fust, Mitchall G. Clark, Jill Henrich, Heather D Turner, William K Heiden, Domain Partners Viii, L.P., and Isaac E. Ciechanover
The most active insider trader at Atara Biotherapeutics Inc is Isaac E Ciechanover with 102 trades.
Isaac E Ciechanover has sold the most Atara Biotherapeutics Inc stock with a total value of $26,010,505.70.
Domain Partners Viii, L.P. has bought the most Atara Biotherapeutics Inc stock with a total value of $5,459,498.00.
The most recent insider trade for Atara Biotherapeutics Inc was on Nov. 18, 2024.
The single biggest insider buy for Atara Biotherapeutics Inc was from Domain Partners Viii, L.P. with a total value of $2,729,749.00 on Oct. 21, 2014.
The single biggest insider sell for Atara Biotherapeutics Inc was from Isaac E Ciechanover with a total value of $2,336,000.00 on July 10, 2018.